David A. Siegel Liva Nova PLC Transaction History
Two Sigma Advisers, LP
- $46.1 Billion
- Q2 2025
A detailed history of David A. Siegel (Two Sigma Advisers, LP) transactions in Liva Nova PLC stock. As of the latest transaction made, Two Sigma Advisers, LP holds 215,145 shares of LIVN stock, worth $11.6 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
215,145
Previous 229,845
6.4%
Holding current value
$11.6 Million
Previous $9.03 Million
7.28%
% of portfolio
0.02%
Previous 0.02%
Shares
27 transactions
Others Institutions Holding LIVN
# of Institutions
274Shares Held
55.5MCall Options Held
75.5KPut Options Held
73.1K-
Black Rock Inc. New York, NY6.9MShares$374 Million0.01% of portfolio
-
Primecap Management CO Pasadena, CA4.64MShares$251 Million0.17% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.45MShares$133 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny2.43MShares$131 Million0.06% of portfolio
-
State Street Corp Boston, MA2.08MShares$113 Million0.0% of portfolio
About LivaNova PLC
- Ticker LIVN
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 53,545,700
- Market Cap $2.9B
- Description
- LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. It operates through three segments: Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support. The Cardiopulmonary segment develops, produces, and sells cardiopulmonary products, including oxygenators, heart-lung machines,...